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Abstract: The present study reports on the production of low molecular weight heparin 
(LMWH) loaded polymeric microspheres for delivery via the oral route. The microspheres 
were prepared by the spray-drying technique using Eudragit® as the polymer. The objective of 
this study was to examine extensively the inﬂ  uence of formulation and process variables on the 
characteristics of the microspheres prepared. The effects of various experimental parameters such 
as polymer concentration, inlet temperature, and liquid feed ﬂ  ow rate on particle morphology, 
particle dimensions, and production yields were evaluated by means of experimental factorial 
designs. Electron microscopy, moisture content analysis, and fractal dimensional analysis were 
employed to characterize the microspheres. The inlet temperature and polymer concentration 
had the greatest effects on the production yield. Results showed that the polymer concentra-
tion affected the dimensions of the microspheres. Drug-loaded microspheres were spherical 
in shape and had a smooth surface with sizes ranging between 19–60 μm. Production yields 
were above 50% under most of the operating parameters studied. The selection of appropriate 
parameters yielded spray-dried microparticles characterized by smooth morphology and narrow 
dimensional distribution.
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Introduction
Spray drying is a well-established drying process traditionally used for thermolabile 
materials (Masters 1990). It has been used successfully in the pharmaceutical industry 
to produce products of deﬁ  ned physical and chemical properties. In this study we have 
investigated spray drying as a potential method for the production of micron-sized 
particles of a LMWH (ardeparin). Spray drying is widely used for the microencapsu-
lation of drugs due to reliability, reproducibility and possible control of particle size 
and drug release. In addition, it has the advantage of being a continuous process which 
is easy to scale-up (Bodmeier and Chen 1998). Another important advantage is the 
fact that microparticles obtained by spray-drying are usually free of organic solvents, 
whereas other methods often result in particles contaminated with organic solvents 
which may be toxic (Broadhead 1992). The spray drying technique consists of spraying 
an emulsion of polymer and drug through the nozzle of a spray dryer apparatus. The 
solvent evaporates very quickly, leaving behind solid microparticles (Conti et al 1992). 
The spray drying process involves the following four sequential stages: atomization 
of the product into a spray nozzle, spray-air contact, drying of the sprayed droplets, 
and collection of the solid product (spray-dried microparticles) obtained (Conti et al 
1992). A stable powder is rapidly obtained without lyophilization. In a single operation 
a drug can be entrapped into a polymer either as a solution, dispersion, or an emulsion 
(Bittner et al 1998). Hydrophobic as well as hydrophilic drugs can be incorporated Drug Design, Development and Therapy 2008:2 40
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into a polymer by spray drying. In this study, the spray dryer 
was a mini-Büchi 190 (Büchi Co., Flawil, Switzerland) which 
is a laboratory scale spray dryer. The main components of 
the equipment include the air-heater, the nozzle/atomizer, 
the desiccation chamber (spray-drying cylinder), the fan, the 
cyclone collector (for separation between the product and the 
air-ﬂ  ow) and a ﬁ  nal collector vessel in which the spray-dried 
product is collected.
The quest for an ideal anticoagulant has resulted in a 
number of oral factor Xa inhibitors and direct thrombin 
inhibitors being introduced in the market. Low molecu-
lar weight heparin (LMWH) is the agent of choice in the 
anti-coagulant therapy and prophylaxis of thrombosis and 
coronary syndromes (Gallus 1992; Weltermann et al 2003). 
However, a major disadvantage of LMWHs is that they can 
only be administered parenterally, due to a lack of absorption 
when administered orally (Grau et al 2001; Breddin et al 
2001; Money and York 2001). The development of oral 
formulations for LMWH would have tremendous clinical 
importance as it would result in avoidance of the pain and 
discomfort associated with injections, thereby offering better 
patient compliance. The intestinal absorption of LMWHs is 
limited owing to their poor membrane permeability charac-
teristics such as hydrophilicity, anionic surface charges and 
high molecular weight (Ross and Toth 2005). Moreover, 
these therapeutic macromolecules are unstable in the acidic 
conditions of the stomach. It has been shown that desulfation 
of heparin may occur in the acidic pH of the stomach (Larsen 
et al 1989). Selective deacetylation and desulfation of heparin 
have been shown to affect both its anticoagulant activity and 
in vivo disposition characteristics (Bjornsson et al 1988). 
Since LMWHs are not absorbed in the gastrointestinal tract, 
recent studies have focused on combining LMWH with car-
riers (Salartash et al 1999; Jiao et al 2002).
Since several polymeric microparticles are proven to 
protect and target drugs, we made use of this formulation 
approach in our study (Esposito et al 2001). A polymer 
belonging to the class of Eudgragit® polymers was selected 
for this study. These polymers are widely accepted in the 
pharmaceutical industry (Esposito et al 2001). The carrier 
chosen was Eudragit S100 which is a methacrylate polymer 
composed of methacrylic acid-methacrylic acid methyl 
ester copolymers. This was chosen for its gastroresistance 
as it is a pH-dependant enterosoluble polymer which is 
soluble above pH 7.0. S100 is a non-biodegradable polyca-
tionic polymer which is generally used for enteric coating 
(Esposito et al 2001). This polymer was chosen for the 
production of microparticles by spray-drying in the current 
study because of its inertness and solubility characteristics 
(Esposito et al 2001). Since spray drying depends on various 
interacting variables and operating conditions, the effects 
of process and formulation variables were investigated. 
The effects of these variables on particle size and yield 
were of primary importance to this study. Other response 
parameters of interest were particle morphology, moisture 
content, encapsulation efﬁ  ciency, in vitro release and fractal 
dimension of the resulting microparticles obtained using the 
spray-drying process.
Materials and methods
LMWH was purchased from Celcus Laboratories Inc. 
(Boston, MA). Eudragit S100 was kindly provided by Rohm 
Pharma (Darmstadt, Germany). The commercial kit used for 
the evaluation of anti-factor Xa activity was purchased from 
Dia-pharma group (Westchester, OH). Other reagents used 
were purchased from Sigma Chemical Co. (St. Louis, MO).
Design of experiments
The design of experiments (DOE) technique was used to pro-
vide an efﬁ  cient means to optimize the spray drying process. 
DOE is an approach for effectively and efﬁ  ciently exploring 
the cause and effect relationship between numerous process 
variables and the output. A sequence of experiments were 
performed that would yield the most information about the 
factors and their interactions in as few experiments as pos-
sible. A 3-factor 3-level factorial Box-Behnken experimental 
design technique was employed to investigate the variables 
using the statistical software package Statvision (Statgraphics, 
Manugistics Inc., Rockville, MD). This technique was 
applied to quantify the inﬂ  uence of operating parameters 
on the production of microparticles during the spray drying 
operation. The fractional factorial design created constituted 
15 of the experiments in this study. The dependant variables 
were polymer concentration, inlet temperature and feed ﬂ  ow 
rate. Preliminary experiments were performed to conﬁ  rm 
the operational phase range that would successfully yield 
spray-dried microparticles and to verify that the runs could 
be conducted at the operational units dictated by the factorial 
design. The software was also used to construct mathematical 
models for making response predictions for further experi-
ments. Graphs showing the magnitude of effects for each 
variable and interactions were generated for analysis. The 
experimental design matrix is shown in Table 1. The goal of 
the experimental design was to ﬁ  nd out, with the minimum 
number of experimental runs, which process variables have 
the biggest impact on the ﬁ  nal product.Drug Design, Development and Therapy 2008:2 41
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Spray-drying procedure
The mini spray dryer employed was a Büchi 290 (Büchi Co., 
Flawil, Switzerland). Aqueous solutions of LMWH ardepa-
rin and Eudragit S100® (methacrylic acid copolymer type B 
MW 135,000) were prepared at their given concentrations in 
puriﬁ  ed water. The various spray-drying process conditions 
are listed in Table 1. Brieﬂ  y, given amounts of S100 were 
dissolved in 100 mL of puriﬁ  ed water and 500 mg of LMWH, 
ardeparin was added to this solution under stirring. The 
resultant mixture was fed into the spray-dryer by a peristaltic 
pump and sprayed with a 0.7 mm nozzle, by means of a ﬂ  ow 
of compressed air, in the drying chamber of the apparatus. 
A ﬂ  ow of heated air aspirated by a pump induced the quick 
evaporation of the solvent from the drops, leading to the 
formation of solid microparticles. The particles were separated 
from the exhausted air in a cyclone and settled into a bottom 
collector using a Model 290 bench top spray dryer (Büchi Co, 
Flawil, Switzerland) using the following settings: pressure 
85 mbar, solvent flow rate 15%–25%, and temperature 
80–100 °C. The drug loading was kept constant for all runs 
at 0.5%. At the end of the spray-drying process, the particles 
were collected and subsequently characterized.
Particle morphology and geometric size
Surface characteristics of the various spray dried microparticles 
were examined using scanning electron microscopy (SEM). 
Dried microparticles were analyzed without sputter coating 
at 15–20 kV. SEM images were obtained for all the runs to 
examine particle morphology. Samples were analyzed using a 
Hitachi S-3400 II Scanning Electron Microscope (Hitachi High 
Technologies America, Inc. Schaumburg, IL). Microsphere size 
was determined by examining the diameter on digital photomi-
crographs. The analysis was performed by a computerized size 
analysis system built into the above SEM system.
Fractal analysis
Fractal dimension was applied to study the surface roughness 
of microparticles. The fractal dimension was measured using 
BenoitTM 1.3 (St. Petersburg, FL). The fractal dimension was 
calculated using the Box-dimension method. The fractal 
dimension Df, is a measure of the particle surface. The SEM 
images were used for the computation of dimensions after 
conversion to a bitmap image ﬁ  le.
Determination of residual moisture 
content
The residual water content for the microparticle samples 
was determined by Karl Fisher titration using a Brinkmann 
756 KF Coulometer (Hamburg, Germany). Typically 10 
mg of sample was dissolved in 1 mL of reagent Hydranal®-
Coulomat AG-H and added to the Karl Fisher titration 
vessel following equilibration of the instrument for moisture 
determination. The moisture content of the anhydrous reagent 
was determined as the baseline and subtracted from data as 
baseline correction (Tattini et al 2005).
Production yield/recovery
Microparticle recovery efﬁ  ciencies were calculated as per-
centage of weight of microparticles obtained compared to 
the total amount of polymer and drug initially used in the 
formulation process.
Results and discussion
Fractal dimension
The fractal concept of Mandelbrot (Mandelbrot 1982) offers 
the theoretical basis for the understanding of the changes 
in boundary lengths due to differences in resolution. The 
surface fractal dimension (Df) is the measure of the space-
ﬁ  lling ability of a curve (Clark 1986). The more irregular 
and unsteady an object is, the higher the value of Df   . This 
has implications in understanding the physical behavior of 
pharmaceutical solids. An advantage of fractal analysis is 
that it partitions roughness characteristics of a surface into a 
scale-free component (fractal dimension). It is an attractive 
method for summarizing properties of roughness (Davies 
1999). The earliest work in fractal analysis has shown that the 
degree of surface roughness or irregularities can be expressed 
by the parameter Df (Avnir and Pfeifer 1983; Farin and Avnir 
1992; Pfeifer 1983). A perfectly smooth surface has a low 
Df value while a highly rough, disordered surface has a high 
Df   . The fractal dimension can be derived from the slope of 
Richardson plots which are linear. The importance of this 
Table 1 Factors and levels in the Box-Behnken design
Levels
Independent variables Low Middle High
X1 = Polymer concentration 
(%)
15 9
X2 = Inlet temperature (°C) 80 90 100
X3 = Feed ﬂ  ow rate (%) 15 20 25
Constraints
Dependent variables Low High Goal
Y1 = Production yield (%) 20 100 maximize
Y2 = Mean particle size (μm) 1 30 minimizeDrug Design, Development and Therapy 2008:2 42
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technique is that the roughness of solid surfaces can now be 
reasonably quantiﬁ  ed. The fractal dimension of solid surfaces 
can be determined using a variety of techniques including 
scanning electron microscopy (Friel and Pande 1998).
The fractal dimension of the particle contour provides 
information on the appearance of the surface that is difﬁ  cult 
to be evidenced even in qualitative form. Table 3 indicates 
that formulation no. 3 had the smoothest surface with fewer 
irregularities while formulation no. 12 had a more irregular 
surface (Table 3). The lowest value for formulation no. 3 
not only conﬁ  rms the SEM observation, but also suggests a 
lower degree of irregularity than that appreciated by direct 
vision. Fractal geometry has been used to determine effects 
of surface morphology on drug dissolution (Farin and Avnir 
1992). In this regard, the Noyes-Whitney equation and 
Hixon-Crowell cube root laws have been modiﬁ  ed to include 
surface roughness effects on the dissolution rate of drugs. 
Surface irregularity and shape allow better contact with the 
dissolution medium and improvement of the dissolution rate 
and therefore, a more efﬁ  cient pharmaceutical form. Thus, the 
particles in our study possessing greater irregularity would 
be able to release drug more efﬁ  ciently.
Inﬂ  uence of operating conditions 
on microsphere characteristics
The input parameters and the resulting responses for the 15 
experimental runs are listed in Table 1. The Box-Behnken 
design is suitable for understanding the quadratic response 
surfaces. The design consists of replicated center points and 
the set of points lying at the mid-point of each surface of 
the cube deﬁ  ning the region of interest. Interaction effects 
between the factors resolved by the design allow a mid-level 
value for a combination of factors (Box 1960).
Qualitative estimates of the inﬂ  uence of the individual 
variables could be made by inspection of the data in Table 2. 
However, it would be difﬁ  cult visually to make predictions 
as to whether the interactions actually existed between the 
variables, or which single variable had the most dominant 
effect. To achieve this, fractional factorial statistical design 
methods were applied to all 15 runs. These designs are good 
alternatives to a full factorial design, especially in the initial 
screening stage. In this study a 3-factorial design was used 
where main factor effects are confounded with two factor 
and higher order interactions. The main effects and interac-
tion effects calculated for the responses of percent yield and 
mean diameter are shown in Figure 1.The variables A, B, and 
C represent polymer concentration, inlet temperature, and 
feed ﬂ  ow rate, respectively. Interactions between two and 
among three variables are shown as AB, BC, AC, and ABC. 
The standardized Pareto Chart shown contains a bar for each 
effect, sorted from most signiﬁ  cant to least signiﬁ  cant. The 
length of each bar is proportional to the standardized effect, 
which is equal to the magnitude of the t-statistic that would 
be used to test the statistical signiﬁ  cance of that effect. A 
vertical line is drawn at the location of the 0.05 critical values 
for Student’s t. Any bars that extend to the right of that line 
indicate effects that are statistically signiﬁ  cant at the 5% sig-
niﬁ  cance level. From the magnitudes of all the effects, inlet 
temperature and polymer concentration appeared to be the 
main factors affecting the percent yield. There was no main 
factor for the effect on particle size. The interactions between 
the variables did not seem very prominent for the percent 
yield or particle size. From the analysis, it is concluded 
that inlet temperature and polymer concentration were the 
important factors affecting yield or recovery of particles. 
The results obtained for all experiments performed revealed 
that the particle size distribution were practically insensitive 
to the spray drying operating parameters. Table 2 indicates 
that the production yield was highest for formulation no. 3 
(59.26%) while it was lowest for both formulation no.’s 2 
and 7 (0%). This difference may be attributed to either higher 
temperature or higher polymer concentration. In terms of 
mean particle size, formulation no. 4 has the smallest size 
(19.62 μm) while formulation no. 3 had the largest size 
Table 2 Box-Behnken experimental design grid and responses 
pertaining to microparticle production
Run 
no.
Polymer 
concentra-
tion (%)
Inlet tem-
perature 
(°C)
Feed ﬂ  ow 
rate (%)
Produc-
tion yield 
(%)
Mean par-
ticle size 
(μm)
1 1 100 20 51.89 26.13
2 1 80 20 0 N/A
3 9 100 20 59.26 42.92
4 5 80 15 23.45 19.62
5 9 90 15 53.37 32.66
6 5 90 20 47.45 25.79
7 1 90 25 0 N/A
8 9 80 20 23.33 22.36
9 5 100 25 56.55 24.98
10 5 80 25 20 40.18
11 9 90 25 18.84 32.78
12 1 90 15 25.33 36.27
13 5 100 15 47.45 25.09
14 5 90 20 28.36 30.54
15 5 90 20 25.82 27.02Drug Design, Development and Therapy 2008:2 43
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(42.92). The operation variable responsible for this cannot 
be isolated from these results.
The yields ranged from 0 to 60%. Most of the runs resulted 
in low yields because of the difﬁ  culties in particle collection. 
Condensation inside the chamber leads to a low yield as the 
dry particles tend to stick to the walls of the chamber and 
therefore cannot be collected. The yield was expected to be 
greater at higher temperature due to the increase throughput 
of the polymer slurry and rapid evaporation of the solvent. 
Dramatic yield losses in formulation no’s 2 and 7 were caused 
by lack of drying at lower temperature and adherence of 
some of the polymer onto the sides of the atomization cham-
ber. Also, the mean diameters at higher temperature were 
increased. Interdroplet agglomeration probably contributed to 
larger mean particle sizes with formulation. Inlet temperature 
of air-drying is an important parameter for both particle size 
and yield. The temperature employed in spray drying opera-
tion has to be compatible with the material to be dried and 
the solvent used (Torrado et al 1989). High pumping rates 
during the spray drying process result in large volumes of 
nebulized solution to be dried. Owing to this, heated air may 
not instantaneously transform the liquid droplets into solid 
microparticles, leading to the formation of larger/irregular 
particles that are not completely dried after leaving the 
desiccating chamber (Wan et al 1991). At higher feed rates, 
the atomizing air may not be able to penetrate the stream 
Table 3 Fractal dimension and residual moisture content for 
microparticles prepared by spray drying
Formulation no. Fractal dimension 
(n = 3) (Df)
Moisture content 
(n = 3) (%)
1 1.74 ± 0.06 4.80 ± 0.05
2 N/A N/A
3 1.4 ± 0.06 4.13 ± 0.01
4 1.72 ± 0.03 4.04 ± 0.02
5 1.55 ± 0.05 3.66 ± 0.03
6 1.67 ± 0.09 5.24 ± 0.10
7 N/A N/A
8 1.54 ± 0.10 2.80 ± 0.07
9 1.59 ± 0.13 3.45 ± 0.01
10 1.76 ± 0.06 3.53 ± 0.10
11 1.59 ± 0.05 4.64 ± 0.12
12 1.87 ± 0.005 4.53 ± 0.10
13 1.69 ± 0.10 5.08 ± 0.05
14 1.63 ± 0.08 5.04 ± 0.01
15 1.58 ± 0.16 5.11 ± 0.08
1 3
5 4
68
11 12
91 0
13 14
15 NativeHeparin
Figure 1 Scanning electron micrographs of spray-dried microparticles and native 
heparin. (Magniﬁ  cation 200X. scale corresponds to 200 μm) Note: no particles 
obtained for run no.’s 2 and 7.Drug Design, Development and Therapy 2008:2 44
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of liquid. As a result, incomplete atomization may lead to 
wider droplet size distribution (Masters, 1990). The reduc-
tion in yield may be attributed to the incomplete atomization 
and drying, resulting in the deposition of a large amount of 
microparticles on the walls of the desiccating chamber and 
the cyclone separator. The spray drying process resulted in a 
range of particle sizes. Five different runs produce the small-
est size and there were no common input conditions for these 
runs. These results are expected as low polymer concentra-
tion decreases the amount of solid in each droplet exiting the 
nozzle. Therefore, when the water in the droplet evaporates, 
a smaller particle remains. Also, when the feed ﬂ  ow rate is 
high, the drop exiting the nozzle tends to be smaller and 
hence the resulting particle will be smaller. The polynomial 
equation (regression) relating dependant (response) and 
independent variables obtained is: Percent Yield = −119.86 
+ 2.42438*Polymer Concentration + 1.85462*Inlet Tem-
perature - 1.35525*Feed Flow Rate To test the statistical 
signiﬁ  cance of the effects, ANOVA was carried out. The 
ANOVA table partitions the variability in percent yield into 
separate pieces for each of the effects. It then tests the statisti-
cal signiﬁ  cance of each effect by comparing the mean square 
against an estimate of the experimental error. In this case, 2 
effects have P-values less than 0.05 indicating that they are 
signiﬁ  cantly different from zero. The R2 statistic indicated 
that the model as ﬁ  tted explains 73.25% of the variability 
in percent yield. The standard error of the estimate shows 
the standard deviation of the residuals to be 11.33. In the 
case of particle size, 1 effect has P-values less than 0.05, 
indicating that they are signiﬁ  cantly different from zero. 
The R2 statistic indicated that the model as ﬁ  tted explains 
37.17% of the variability in particle size. The adjusted R2 
statistic, which is more suitable for comparing models with 
different numbers of independent variables, is 20.03%. The 
standard error of the estimate shows the standard deviation 
of the residuals to be 10.98. To fully understand the ﬁ  tted 
model, a wire frame surface plot was created (Figure 2). In 
this plot, the height of the surface represents the predicted 
value of yield over the space of temperature and polymer 
concentration; with the third factor ie, feed ﬂ  ow rate held 
constant at its middle values. A similar plot was made for 
the particle size response (Figure 3).
Prediction of theoretical response values 
(Response Optimization)
After establishing the relationship between the dependant 
and independent variables, the process was optimized. A 
computerized optimization procedure was used to obtain the 
levels of polymer concentration, inlet temperature and feed 
ﬂ  ow rate at which a maximized percent yield and particle 
size could be obtained. The combination of factor levels 
leading to attainment of maximum response was 9%, 100 °C, 
and 15% for polymer concentration, inlet temperature and 
feed ﬂ  ow rate, respectively. The predicted optimum values 
found were 67.03 and 40.87 for percent yield and particle 
size, respectively.
Scanning electron microscopy
The particle morphologies observed were smooth spheres 
(no’s 3, 5, 10, 11, and 12) and collapsed particles (1, 4, 6, 8, 
and 9). Examples of these can be seen in the images shown 
in Figure 1. The ﬁ  gure indicates that formulation no’s 3 and 
11 possess uniform spherical morphology characteristics. 
The common factor in these two cases was the polymer con-
centration at 9%. SEM studies of the remaining formulation 
numbers indicated the formation of collapsed microparticles. 
Microparticles made at low polymer concentration of 1% 
were poorly formed. The viscosity of the polymer solution 
was too low to maintain the stability of the droplets during 
spray-drying. Higher concentration and higher viscosity of 
the polymer solution resulted in good droplet stability. The 
SEM micrograph of the native drug illustrates large crystal-
line particles while the SEM micrographs of the spray dried 
particles indicate smooth surfaces which are much smaller 
in size when compared with the drug. The particle size is an 
important parameter in drug design and delivery. For exam-
ple, decreasing the particle size increases the surface area, 
which enhances the dissolution rate (Kondo et al 1993).
Production yields
The yields ranged from 0% to 60%. Most of the runs resulted 
in low yields because of the difﬁ  culties in particle collection. 
Condensation inside the chamber leads to a low yield as the 
dry particles tend to stick to the walls of the chamber and 
therefore cannot be collected.
Moisture content
The moisture content of a powder inﬂ  uences ﬂ  ow and dis-
persion from the perspective of capillary forces and liquid 
bridging between the particles. The strength of the cohesive 
force depends on the surface tension, wetting angle, space 
between the particles and particle diameter. The same particle 
characteristics that result in moisture uptake will inﬂ  uence 
dissolution properties. This parameter is also important for 
the prediction of the ﬂ  ow behavior of the product in the tablet-
ting machines or in the encapsulation machines during the Drug Design, Development and Therapy 2008:2 45
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preparation of pharmaceutical dosage forms. Table 3 shows 
the results obtained. It can be observed that the temperature 
is the most important parameter for the product moisture 
content. In general, higher temperatures lead to a product 
with lower moisture content. In terms of residual moisture 
content, formulation no. 8 was found to be the best due to 
lowest water content (2.80%). This was in compliance with 
USP requirements for product storage (USP 1994).
Conclusions
Microparticles were successfully prepared by spray-drying 
technique. SEM micrographs showed that the particles sizes 
of the various formulations ranged from 19 to 60 μm and that 
the surfaces were smooth in appearance. The factorial design 
proved to be a valuable technique for optimizing the production 
of spray-dried microparticles. Since spray-drying involved 
various parameters for study, the number of experiments was 
minimized while a detailed evaluation of the dominant variable 
effects and interactions was accomplished. The conditions 
for obtaining microparticles with optimal yield (67.03%) and 
mean diameter (40.87 μm) under the operating conditions used 
were determined. Highest yields (56%) were obtained with 
highest temperature (100 °C) and at a polymer concentration of 
9%. Smallest particle size (19 μm) was obtained with the tem-
perature at 80 °C and a polymer concentration of 5%. Results 
indicate that the pH-sensitive polymer may protect LMWH 
against acidic pH after microencapsulation using the spray dry-
ing technique. This approach may contribute to enhanced oral 
bioavailability of LMWHs. This work conﬁ  rms the feasibility 
of the spray drying for the preparation of microparticulate 
Standardized pareto chart for particle size
Standardized effect
+
−
0
C:Feed flow rate
B:Inlet temperature
A:Polymer concentration
0.4 0.8 1.2 1.6 2 2.4
Standardized pareto chart for percent yield
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+
−
0
C:Feed flow rate
A:Polymer concentration
B:Inlet temperature
5 4 3 1 2
Figure 2 Standardized Pareto chart for main effects of experimental parameters on the responses.Drug Design, Development and Therapy 2008:2 46
Motlekar and Youan
systems with incorporated controlled-release mechanism to 
modify LMWH release. Results indicate that the drug release 
rate from microparticles can be controlled by a proper choice 
of polymer type, polymer amount and, spray drying operating 
conditions such as the inlet temperature and feed rate of the 
microencapsulating composition. One limitation of this study 
is that the stability of the drug within the microparticles has 
not been determined. This data would be useful to determine 
whether the polymer interacts in a signiﬁ  cant manner with 
the LMWH contained within the particles. Further research 
is needed before this study can provide important clinical rel-
evance with regards to anti-coagulant therapy. Future studies 
describing the in vivo absorption and anti-coagulant activity 
of the formulation in an appropriate animal model will aid 
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Figure 3 Response surface wire frame plot with contours below for (a) percent yield and (b) particle size as a function of the spray drying operating parameters.Drug Design, Development and Therapy 2008:2 47
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in determining the potential of these microparticles for suc-
cessfully overcoming the challenges faced in the delivery of 
LMWH via the oral route.
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